Most cases are caused by either Neisseria gonorrhoeae or Chlamydia trachomatis. Other causative organisms include Mycoplasma genitalium, Ureaplasma urealyticum, Trichomonas vaginalis, HSV, and occasionally anaerobes (especially Leptotrichia/Sneathia species) involved in bacterial vaginitis. Chlamydia causes 30-40% of nongonococcal urethritis (NGU) cases. M. genitalium is the probable cause in many Chlamydia-negative cases of NGU.
Urethritis in men produces urethral discharge, dysuria, or both, usually without frequency of urination.
Pts present with a mucopurulent urethral discharge that can usually be expressed by milking of the urethra; alternatively, a Gram's-stained smear of an anterior urethral specimen containing ≥2 PMNs/1000× field confirms the diagnosis.
TREATMENT | ||
Urethritis in Men
|
Microbiology
In sexually active men <35 years old, epididymitis is caused most frequently by C. trachomatis and less commonly by N. gonorrhoeae.
Clinical Manifestations
Acute epididymitis-almost always unilateral-produces pain, swelling, and tenderness of the epididymis, with or without symptoms or signs of urethritis. Epididymitis must be differentiated from testicular torsion, tumor, and trauma. If symptoms persist after treatment, a testicular tumor or a chronic granulomatous disease (e.g., tuberculosis) should be considered.
TREATMENT | ||
Epididymitis
|
Urethritis (the Urethral Syndrome) In Women
Microbiology and Clinical Manifestations
C. trachomatis, N. gonorrhoeae, and occasionally HSV cause symptomatic urethritis-known as the urethral syndrome in women-that is characterized by internal dysuria (usually without urinary urgency or frequency), pyuria, and an absence of Escherichia coli and other uropathogens at counts ≥102 /mL in urine.
Diagnosis
Specific tests (e.g., NAATs of vaginal secretions collected with a swab) are used to evaluate for infection with N. gonorrhoeae or C. trachomatis.
TREATMENT | ||
Urethritis (The Urethral Syndrome) in WomenSee Urethritis in Men Sexually Transmitted and Reproductive Tract Infections, above. |
A variety of organisms are associated with vulvovaginal infections, including N. gonorrhoeae and C. trachomatis (particularly when they cause cervicitis), T. vaginalis, Candida albicans, Gardnerella vaginalis, and HSV.
Vulvovaginal infections encompass a wide array of specific conditions, each of which has different presenting symptoms.
Evaluation of vulvovaginal symptoms includes a pelvic examination (with a speculum examination) and diagnostic testing.
TREATMENT | ||
Vulvovaginal Infections
|
N. gonorrhoeae, C. trachomatis, and M. genitalium are the primary causes of mucopurulent cervicitis. Of note, NAATs for these pathogens, HSV, and T. vaginalis have been negative in nearly half of cases.
Mucopurulent cervicitis represents the silent partner of urethritis in men and results from inflammation of the columnar epithelium and subepithelium of the endocervix.
Yellow mucopurulent discharge from the cervical os, with ≥20 PMNs/1000× field on Gram's stain of cervical mucus, indicates endocervicitis. The presence of intracellular gram-negative diplococci on Gram's stain of cervical mucus is specific but <50% sensitive for gonorrhea; thus NAATs for N. gonorrhoeae and C. trachomatis are always indicated.
TREATMENT | ||
Mucopurulent CervicitisSee Urethritis in Men Sexually Transmitted and Reproductive Tract Infections, above. |
Pelvic Inflammatory Disease (Pid)
The agents most often implicated in acute PID-infection that ascends from the cervix or vagina to the endometrium and/or fallopian tubes-include the primary causes of endocervicitis (e.g., N. gonorrhoeae, C. trachomatis, M. genitalium) and anaerobes associated with BV; other organisms (e.g., Prevotella spp., peptostreptococci, E. coli, Haemophilus influenzae, and group B streptococci) account for 25-33% of cases.
In 2014, there were 51,000 visits to physicians' offices for PID in the United States; there are ∼70,000-100,000 hospitalizations related to PID annually.
The presenting symptoms depend on the extent to which the infection has spread.
Speculum examination shows evidence of mucopurulent cervicitis in the majority of pts with gonococcal or chlamydial PID; cervical motion tenderness, uterine fundal tenderness, and/or abnormal adnexal tenderness also is usually present. Vaginal or endocervical swab specimens should be obtained for NAATs for N. gonorrhoeae and C. trachomatis.
TREATMENT | ||
Pelvic Inflammatory Disease
|
Prognosis
Late sequelae include infertility (11% after one episode of PID, 23% after two, and 54% after three or more); ectopic pregnancy (sevenfold increase in risk); chronic pelvic pain; and recurrent salpingitis.
The most common etiologies for ulcerative genital lesions in the United States are genital herpes, syphilis, and chancroid. See Table 86-1 Clinical Features of Genital Ulcers and the sections on individual pathogens below for specific clinical manifestations. Pts with persistent genital ulcers that do not resolve with syndrome-based antimicrobial therapy should have their HIV serologic status assessed if such testing has not previously been performed. Immediate treatment (before all test results are available) is often appropriate to improve response, reduce transmission, and cover pts who might not return for follow-up visits.
Proctitis, Proctocolitis, Enterocolitis, and Enteritis
Acquisition of HSV, N. gonorrhoeae, or C. trachomatis (including lymphogranuloma venereum [LGV] strains of C. trachomatis) during receptive anorectal intercourse causes most cases of infectious proctitis in women and in men who have sex with men (MSM). Sexually acquired proctocolitis is most often due to Campylobacter or Shigella spp. In MSM without HIV infection, enteritis is often attributable to Giardia lamblia.
Anorectal pain and mucopurulent, bloody rectal discharge suggest proctitis or proctocolitis. Proctitis is more likely to cause tenesmus and constipation, whereas proctocolitis and enteritis more often cause diarrhea.
TREATMENT | ||
Proctitis, Proctocolitis, Enterocolitis, Enteritis
|
Section 7. Infectious Diseases